is semaglutide on shortage list US judge upholds FDA's removal of Ozempic, Wegovy from drug FDA Ends Semaglutide Shortage Listing,

PALO ALTO, Calif., September 28, 2023 (BUSINESS WIRE)-- Digbi Health, the leader in precision biology-based telehealth care for three of the top four healthcare costs - Obesity, T2D, and Digestive Health - announced today the launch of its latest innovation in obesity care,Digbi GLP-Fit, a scientifically-backed approach to identify the best treatment path for an individual to prevent and treat obesity. Key Highlights: Digbi GLP-Fituses the science of precision biology to identify the best treatment path for obesity for an individual with 87% accuracy, which may include 1) only precision nutrition, 2) a combination of precision nutrition and lower-cost drugs like Metformin, or 3) a combination of precision nutrition and GLP-1 medications

Semaglutide was approved in 2017 as Ozempic for diabetes, and in 2021 as Wegovy for obesity

GLP-1 medications help curb appetite, but without the right support, they can leave your body depleted of essential nutrients

Enclomiphene raises testosterone naturally by targeting the HPG axis, preserving fertility where TRT cannot

Semaglutide ameliorates metabolism and hepatic outcomes in an NAFLD mouse model